KEDPLASMA

kedrion.com

KEDPLASMA specializes in the collection of high-quality plasma that is processed into plasma-based therapies to respond to patients’ needs the world over. KEDPLASMA is a subsidiary of Kedrion Biopharma, an international company that produces and distributes plasma-derived medicinal products for use in treating serious disorders such as hemophilia and immune system deficiencies.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMA TECH

AION LABS WELCOMES AMITI AS STRATEGIC PARTNER TO ACCELERATE ISRAEL'S POSITION AS A LEADING HUB FOR TRANSFORMATIVE AI-POWERED DRUG DISCOVERY INNOVATION

PR Newswire | January 09, 2024

news image

AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced today a new strategic partnership with Amiti Ventures, one of the leading early-stage venture capital firms in Israel. The partnership further strengthens the alliance of global leaders in pharma, biotech, and technology investment, expanding its offering as a venture studio and partner for new startups. "With a pr...

Read More

MAJOR PHARMA COMPANIES INCLUDING NOVARTIS AND MERCK BUILD FEDERATED LEARNING PLATFORM FOR DRUG DISCOVERY

Venturebeat | September 17, 2020

news image

Last June, 10 major pharmaceutical companies — Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Institut De Recherches Servier, Janssen, Merck, and Novartis — inked an agreement to build a shared platform called MELLODDY (Machine Learning Ledger Orchestration for Drug Discovery). In partnership with Nvidia, Owkin, and other tech partners, the group sought to leverage techniques like federated learning to collectively train AI on datasets without having to share any pro...

Read More

APRICUS HEALTH PARTNERS WITH MEDICARE ADVANTAGE PLAN DEVOTED HEALTH AND FULL-SERVICE RETAIL PHARMACY LITON RX

Apricus Health | November 04, 2020

news image

Apricus Health, an innovative healthcare company delivering high impact, relationship-based care, today announced two new partnerships that provide its members with extraordinary services. Medicare Advantage plan provider Devoted Health and full-service retail pharmacy Liton Rx are now partnering with the Apricus Health Network which is designed by Arizona physicians. "We are committed to helping our members with a range of quality services to improve health outcomes and significantly...

Read More

Business Insights

EX-BIOCON TEAM SYMBIO GENERRICS COMPLETES CAPITAL RAISE FROM ASCENT CAPITAL

Symbio Generrics | November 25, 2022

news image

Symbio Generrics India Private Limited a specialized Active Pharmaceutical Ingredients & Intermediates manufacturing and marketing organization, announced that it has completed an equity capital raise from Ascent Capital, a leading growth-capital focused private equity fund. Symbio was founded by pharmaceutical professionals, Salim Shaikh and Abhijit Kale. They were soon joined by the third promoter, Akash Puranik; all of whom possess decades of experience in the global pharma...

Read More
news image

PHARMA TECH

AION LABS WELCOMES AMITI AS STRATEGIC PARTNER TO ACCELERATE ISRAEL'S POSITION AS A LEADING HUB FOR TRANSFORMATIVE AI-POWERED DRUG DISCOVERY INNOVATION

PR Newswire | January 09, 2024

AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced today a new strategic partnership with Amiti Ventures, one of the leading early-stage venture capital firms in Israel. The partnership further strengthens the alliance of global leaders in pharma, biotech, and technology investment, expanding its offering as a venture studio and partner for new startups. "With a pr...

Read More
news image

MAJOR PHARMA COMPANIES INCLUDING NOVARTIS AND MERCK BUILD FEDERATED LEARNING PLATFORM FOR DRUG DISCOVERY

Venturebeat | September 17, 2020

Last June, 10 major pharmaceutical companies — Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Institut De Recherches Servier, Janssen, Merck, and Novartis — inked an agreement to build a shared platform called MELLODDY (Machine Learning Ledger Orchestration for Drug Discovery). In partnership with Nvidia, Owkin, and other tech partners, the group sought to leverage techniques like federated learning to collectively train AI on datasets without having to share any pro...

Read More
news image

APRICUS HEALTH PARTNERS WITH MEDICARE ADVANTAGE PLAN DEVOTED HEALTH AND FULL-SERVICE RETAIL PHARMACY LITON RX

Apricus Health | November 04, 2020

Apricus Health, an innovative healthcare company delivering high impact, relationship-based care, today announced two new partnerships that provide its members with extraordinary services. Medicare Advantage plan provider Devoted Health and full-service retail pharmacy Liton Rx are now partnering with the Apricus Health Network which is designed by Arizona physicians. "We are committed to helping our members with a range of quality services to improve health outcomes and significantly...

Read More
news image

Business Insights

EX-BIOCON TEAM SYMBIO GENERRICS COMPLETES CAPITAL RAISE FROM ASCENT CAPITAL

Symbio Generrics | November 25, 2022

Symbio Generrics India Private Limited a specialized Active Pharmaceutical Ingredients & Intermediates manufacturing and marketing organization, announced that it has completed an equity capital raise from Ascent Capital, a leading growth-capital focused private equity fund. Symbio was founded by pharmaceutical professionals, Salim Shaikh and Abhijit Kale. They were soon joined by the third promoter, Akash Puranik; all of whom possess decades of experience in the global pharma...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us